2,3 In REDEFINE 1, adverse events were mainly gastrointestinal, (79.6% in the CagriSema group vs 39.9% with placebo) including nausea (55% vs 12.6%), constipation (30.7% vs 11.6%), and vomiting (26.1% vs 4.1%)
As a result, greater weight loss is achieved over time, as more calories are burned than with standard dietary restrictions or exercise alone
If they persist beyond 4 weeks or worsen during dose escalation, contact your PlexusDx provider to discuss slower titration, hydration strategies, or alternative delivery methods
What can you do to lower your risk if you use this medicine
This personalized approach ensures that if you do experience unexpected symptoms, you have a team ready to help you adjust your plan
That is the somewhat obscure origin story of todays weight loss drugs, which involves the venom of the Gila monster